Free for a week, then $19 for your first month
Expert Advice

The Compliance Playbook for Using AI Notes Across Multi-Location Practices

Navigate AI documentation compliance across multi-location practices.

Four clinic locations networked to a central compliance shield with a checkmark — consistent HIPAA compliance across a multi-location practice.

The adoption of AI scribes has been revolutionizing clinical documentation and significantly reducing clinician burnout. However, implementing this technology across multiple locations introduces a dangerous variable: inconsistency. A single site's overlooked vulnerability can compromise the entire healthcare enterprise. To successfully scale, healthcare organizations must shift to a unified playbook. This guide provides the essential framework for standardizing vendor vetting, training protocols, and continuous audits to ensure HIPAA-compliant AI notes across every practice in your network.

1. The HIPAA Foundation: What Makes an AI Note Tool Compliant?

Any AI vendor handling Protected Health Information (PHI) must sign a Business Associate Agreement (BAA) with your practice. This legally binding contract shifts responsibility for data protection to the vendor and makes them accountable under HIPAA.

The Five Pillars of HIPAA-Compliant AI Notes

For an AI note‑taking tool to be truly HIPAA‑compliant across a multi‑location practice, it must demonstrate the following:

Compliance Pillar

What it Means

Why it Matters for Multi-Location Practices

End-to-End Encryption

AES-256 encryption at rest and TLS 1.3 in transit

Protects data as it moves between locations and devices

Zero Audio Retention

Immediate deletion of recordings after transcription

Eliminates the largest security vulnerability

Automatic PHI Redaction

Removing addresses, and identifiers from transcripts

Ensures consistency across all sites regardless of provider diligence

Role-Based Access Control

Granular permissions so staff see only what they need to

Prevents cross-location data exposure

Audit Trails

Logs showing who accessed what data and when

Enables root-cause analysis across distributed sites

The Data Training Risk

One of the most overlooked HIPAA risks is how vendors use your data. Many consumer‑grade AI tools use customer data to "train" their models. In a healthcare context, this is a serious HIPAA violation; patient details could technically "leak" into the AI's future responses for other users.

See more information on free vs. paid AI note tools.


2. The Multi-Location Challenge: Why Scale Changes Everything

When rolling out AI notes across multiple locations, consistency is very important. Different sites cannot interpret compliance requirements differently.

Key Considerations For Multi-Location Consistency:

  • Standardized Vendor Selection: One approved AI note tool for all locations.
  • Training Programs: Every provider completes the same compliance training.
  • Centralized BAA Management: Track all vendor agreements from a single dashboard.
  • Consistent Patient Consent Protocols: The same disclosure language across every site
Four things that must be identical at every location: standardized vendor, training programs, centralized BAA management, and consistent patient-consent language.

Data Residency and Cross-Border Compliance

For practices operating across state lines, data residency becomes a critical concern. Compliance extends beyond server location to include ETL pipelines, AI APIs, cloud regions, logging systems, and cross‑border data transfers.

Different states may have additional privacy requirements beyond HIPAA, and while HIPAA-compliant AI tools typically meet state requirements automatically, practices must verify compliance for each specific location.

The Human-in-the-Loop Mandate

In 2026, an error generated by an AI is now viewed as a "failure of supervision". For multi‑location practices, this means:

  • Every AI-generated note must be reviewed, edited, and finalized by a licensed provider.
  • Automation bias, the tendency to trust AI suggestions even when they contradict clinical judgment, must be actively counteracted.

3. The Compliance Checklist: Vetting AI Notes for Multi-Location Deployment

Before setting up any AI note‑taking tool across your practice locations, complete this due diligence checklist:

An eight-point checklist for vetting an AI notes vendor before multi-location deployment: BAA at signup, built for healthcare, zero audio retention, AES-256 and TLS 1.3 encryption, no model training on your data, published sub-processor list, EHR integration, and role-based access controls.
  1. Does the vendor sign a BAA at signup, not as an "add-on"?
  2. Is the tool built specifically for healthcare (not a generic AI like standard ChatGPT)?
  3. Does the vendor practice zero-audio-retention, processing in real-time, and discarding immediately?
  4. Is data encrypted with AES-256 (at rest) and TLS 1.3 (in transit)?
  5. Does the vendor explicitly prohibit using your data for model training?
  6. Is there a published sub-processor list so you know where PHI flows?
  7. Does the tool integrate with your EHR?
  8. Does the platform support role-based access controls appropriate for your organizational structure?

Ongoing Operational Compliance

Once set up, multi‑location practices must maintain:

  • Vendor Contract Management: Track all BAAs, renewal dates, and compliance certifications.
  • Regular Security Audits: These must be conducted at the enterprise level, not site-by-site.
  • Incident Response Protocols: Standardized procedures for any data breach, regardless of where it occurs.
  • Provider Attestation Logs: Document that every AI-generated note was reviewed by a licensed clinician.
  • Version Control Tracking: Maintain an "AI Compliance Log" tracking which model version generated each note.

Conclusion

For multi‑location practices, HIPAA-compliant AI notes aren't just about avoiding fines; they're about building patient trust, reducing clinician burnout, and creating operational efficiency at scale. Practices that build strong compliance frameworks now, with centralized vendor management, standardized training, and consistent implementation across all locations, will be positioned to leverage AI's full potential while maintaining the trust and security that patients deserve.


References

FAQ

Frequently asked questions

  • Is every AI note-taking tool with a signed Business Associate Agreement (BAA) automatically HIPAA-compliant?

    No. A signed BAA is a mandatory starting point, but it is not a comprehensive guarantee of compliance. True HIPAA compliance requires the tool to implement specific technical and administrative safeguards across the entire data lifecycle.

    Key Requirements Beyond the BAA:

    • Zero-Audio Retention: The tool must process audio in real-time and delete recordings immediately after note generation. Storing audio files creates a massive security vulnerability.
    • End-to-End Encryption: Data must be secured in transit (TLS 1.3) and at rest (AES-256).
    • Automatic PHI Redaction: The system should automatically remove identifying information from transcripts.
    • No Data Training: The vendor must explicitly confirm that your patient data is not used to train their global AI models. Using PHI for model training without proper authorization can be a HIPAA violation.

    Best Practice: Use this 12-point vendor checklist that verifies each of these safeguards, not just the BAA.


  • Who is legally responsible if an AI-generated clinical note contains an error or hallucination?

    The clinician who signs the note. An error generated by an AI is viewed as a failure of supervision.

    Key Accountability Points:

    • AI-generated notes become part of the legal medical record only after they are reviewed, edited, and signed by a clinician.
    • Clinicians must carefully review AI-assisted notes line by line and correct any inaccuracies before signing.
    • AI can "hallucinate", i.e., fabricate clinical information or misattribute details to the wrong patient. This creates both compliance and malpractice exposure.
  • What patient consent is required when using AI note-taking tools across multiple locations?

    Informed consent is required, and best practice is to obtain written consent annually. Because AI scribes actively listen to and transcribe patient conversations, they are collecting Protected Health Information (PHI), which triggers consent obligations under HIPAA and many state laws.

    Consent Best Practices For Multi‑Location Practices:

    • Remind patients of the technology at the beginning of each encounter.
    • Use consistent consent language across all practice locations to ensure uniform compliance
    • Respect patient choice; providers must accommodate patients who opt out of using AI scribes during their visits.

    See best practices for when patients refuse recording.